Pubblicazioni

Response to 'Is there a future for hydroxychloroquine/chloroquine in prevention of SARS-CoV-2 infection (COVID-19)?' by Moiseev et al

2021 - ANNALS OF THE RHEUMATIC DISEASES

Spinelli, F. R.; Ceccarelli, F.; Di Franco, M.; Conti, F.

SAveRUNNER: A network-based algorithm for drug repurposing and its application to COVID-19

2021 - PLOS COMPUTATIONAL BIOLOGY

Fiscon, G.; Conte, F.; Farina, L.; Paci, P.

SAveRUNNER: an R-based tool for drug repurposing

2021 - BMC BIOINFORMATICS

Fiscon, G.; Paci, P.

Antiviral and immunomodulatory interferon-beta in high-risk COVID-19 patients. A structured summary of a study protocol for a randomised controlled trial

2021 - TRIALS

AricÃ², Eleonora; Castiello, Luciano; Bracci, Laura; Urbani, Francesca; Lombardo, Flavia; Bacigalupo, Ilaria; Ancidoni, Antonio; Vanacore, Nicola; Falcione, Alessandro; Reggiani, Chiara; Dutti, Giovanni Marco; Maglie, Maria Grazia; Papa, Ombretta; Bartoletti, Pier Luigi; Ozzella, Giuseppina; Bevilacqua, Nazario; Nicastri, Emanuele; Belardelli, Filippo; Sconocchia, Giuseppe

Oxygen sparing effect of bacteriotherapy in covid-19

2021 - NUTRIENTS

Ceccarelli, G.; Marazzato, M.; Celani, L.; Lombardi, F.; Piccirilli, A.; Mancone, M.; Trinchieri, V.; Pugliese, F.; Mastroianni, C. M.; D'ettorre, G.

Directly acting antivirals are safe and effective in HCV positive patients aged 80 years and older: a multicenter real-life study

2021 - EXPERT OPINION ON DRUG SAFETY

Pugliese, N.; Giorgini, A.; Maggi, D.; Capogreco, A.; Dibenedetto, C.; Lubrano Lobianco, F.; Dal Buono, A.; Monico, S.; Meli, R.; Battezzati, P. M.; Lleo, A.; De Santis, A.; Zuin, M.; Aghemo, A.

Characterization of the trans-epithelial transport of green tea (C. sinensis) catechin extracts with in vitro inhibitory effect against the sars-cov-2 papain-like protease activity

2021 - MOLECULES

Montone, C. M.; Aita, S. E.; Arnoldi, A.; Capriotti, A. L.; Cavaliere, C.; Cerrato, A.; Lammi, C.; Piovesana, S.; Ranaldi, G.; Lagana, A.